Skip to main content
VCbacked
Log inGet Started

Cinclus Pharma

Mölndal, Sweden

Cinclus Pharma is a research based biotech company.

$9.2M raised
Mar 2026
Post-IPO Debt
BiotechnologyClinical TrialsHealth CarePharmaceutical

Top Investors

Trill ImpactClaret Capital PartnersEIR VenturesFourth Swedish National Pension FundIrrus Investments

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cinclus Pharma

How much funding has Cinclus Pharma raised?
Cinclus Pharma has raised $9.2M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2026.
Who are Cinclus Pharma's investors?
Cinclus Pharma's investors include Trill Impact, Claret Capital Partners, EIR Ventures, Fourth Swedish National Pension Fund, Irrus Investments.
Where is Cinclus Pharma headquartered?
Cinclus Pharma is headquartered in Mölndal, Sweden.
What does Cinclus Pharma do?
Cinclus Pharma is a research based biotech company.
What stage is Cinclus Pharma at?
Cinclus Pharma is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cinclus Pharma — Funding & Investors." VCBacked, March 13, 2026, https://www.vcbacked.co/company/cinclus-pharma. Accessed July 4, 2026.
APA
VCBacked. (2026). Cinclus Pharma — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/cinclus-pharma
Wikipedia (cite web)
{{cite web |title=Cinclus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/cinclus-pharma |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K